The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Mediware Information Systems, Inc. ( the “Company”) (NASDAQ: MEDW), concerning the proposed acquisition of the Company by Thoma Bravo LLC. The current value of the per-share consideration is approximately $22.00, and the total value of the transaction is approximately $1.95 million.
The investigation is focused on the potential unfairness of the consideration to Mediware shareholders, the process by which the Company’s Board of Directors considered the transaction, and potential conflicts of interests among Mediware Board members.
If you are interested in discussing your rights as a Mediware shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (202) 337-8000 or by email at
Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.
To learn more about Finkelstein Thompson LLP, please visit our web site at
. Attorney advertising. Prior results do not guarantee similar outcomes.